- Home
- UNTY vs CTNM Comparison
UNTY vs CTNM Comparison
Compare UNTY & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNTY
- CTNM
- Stock Information
- Founded
- UNTY 1991
- CTNM 2009
- Country
- UNTY United States
- CTNM United States
- Employees
- UNTY N/A
- CTNM N/A
- Industry
- UNTY Major Banks
- CTNM
- Sector
- UNTY Finance
- CTNM
- Exchange
- UNTY Nasdaq
- CTNM Nasdaq
- Market Cap
- UNTY 453.3M
- CTNM 378.7M
- IPO Year
- UNTY 1997
- CTNM 2024
- Fundamental
- Price
- UNTY $46.16
- CTNM $14.06
- Analyst Decision
- UNTY Buy
- CTNM Strong Buy
- Analyst Count
- UNTY 2
- CTNM 4
- Target Price
- UNTY $47.50
- CTNM $29.25
- AVG Volume (30 Days)
- UNTY 25.3K
- CTNM 82.5K
- Earning Date
- UNTY 01-10-2025
- CTNM 11-06-2024
- Dividend Yield
- UNTY 1.12%
- CTNM N/A
- EPS Growth
- UNTY 2.66
- CTNM N/A
- EPS
- UNTY 3.90
- CTNM N/A
- Revenue
- UNTY $100,814,000.00
- CTNM N/A
- Revenue This Year
- UNTY N/A
- CTNM N/A
- Revenue Next Year
- UNTY $11.86
- CTNM N/A
- P/E Ratio
- UNTY $11.86
- CTNM N/A
- Revenue Growth
- UNTY 0.72
- CTNM N/A
- 52 Week Low
- UNTY $25.33
- CTNM $12.33
- 52 Week High
- UNTY $48.44
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- UNTY 57.35
- CTNM N/A
- Support Level
- UNTY $45.79
- CTNM N/A
- Resistance Level
- UNTY $48.44
- CTNM N/A
- Average True Range (ATR)
- UNTY 1.30
- CTNM 0.00
- MACD
- UNTY -0.16
- CTNM 0.00
- Stochastic Oscillator
- UNTY 42.13
- CTNM 0.00
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.